{"url_path":"/sec/aptof/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 LEGAL PROCEEDINGS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/882361/0001193125-26-221955-index.html","accession_number":"0001193125-26-221955","cik":"0000882361","ticker":"APTOF","issuer_name":"Aptose Biosciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/882361/0001193125-26-221955-index.html","primary_entity_key":"0000882361","primary_entity_name":"Aptose Biosciences Inc."},"word_count":71,"has_tables":true,"body_markdown":"ITEM 1 – LEGAL PROCEEDINGS\n\nWe are not involved in any material active legal actions. However, from time to time, we may be subject to various pending or threatened legal actions and proceedings, including those that arise in the ordinary course of our business. Such matters are subject to many uncertainties and to outcomes that are not predictable with assurance and that may not be known for extended periods of time."}